{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:02:49Z","timestamp":1778338969989,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["K12 HS023011"],"award-info":[{"award-number":["K12 HS023011"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00403-020-02098-7","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T06:13:29Z","timestamp":1593756809000},"page":"245-253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The inpatient burden and comorbidities of pyoderma gangrenosum in adults in the United States"],"prefix":"10.1007","volume":"313","author":[{"given":"Shanthi","family":"Narla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan I.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,3]]},"reference":[{"issue":"6","key":"2098_CR1","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/iwj.12939","volume":"15","author":"P Monari","year":"2018","unstructured":"Monari P, Moro R, Motolese A et al (2018) Epidemiology of pyoderma gangrenosum: results from an Italian prospective multicentre study. Int Wound J 15(6):875\u2013879","journal-title":"Int Wound J"},{"issue":"3","key":"2098_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1080\/09546630410031909","volume":"15","author":"D Vidal","year":"2004","unstructured":"Vidal D, Puig L, Gilaberte M, Alomar A (2004) Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features. J Dermatol Treat 15(3):146\u2013152","journal-title":"J Dermatol Treat"},{"issue":"3","key":"2098_CR3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1440-0960.2011.00750.x","volume":"52","author":"A Saracino","year":"2011","unstructured":"Saracino A, Kelly R, Liew D, Chong A (2011) Pyoderma gangrenosum requiring inpatient management: a report of 26 cases with follow up. Australas J Dermatol 52(3):218\u2013221","journal-title":"Australas J Dermatol"},{"issue":"5","key":"2098_CR4","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.jaad.2015.08.009","volume":"73","author":"DW Brodell","year":"2015","unstructured":"Brodell DW, Elfar JC, Mercurio MG (2015) Pyoderma gangrenosum and inflammatory bowel disease: a cross-sectional inpatient socioeconomic study. J Am Acad Dermatol 73(5):877\u2013880","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2098_CR5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jaad.2018.02.007","volume":"79","author":"BH Kaffenberger","year":"2018","unstructured":"Kaffenberger BH, Hinton A, Krishna SG (2018) The impact of underlying disease state on outcomes in patients with pyoderma gangrenosum: a national survey. J Am Acad Dermatol 79(4):659\u2013663.e652","journal-title":"J Am Acad Dermatol"},{"key":"2098_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.05.007","author":"BH Kaffenberger","year":"2018","unstructured":"Kaffenberger BH, Hinton A, Krishna S (2018) The validity of pyoderma gangrenosum ICD9-CM coding in hospital administrative datasets. J Am Acad Dermatol. https:\/\/doi.org\/10.1016\/j.jaad.2018.05.007","journal-title":"J Am Acad Dermatol"},{"key":"2098_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1750-1172-8-136","volume":"8","author":"P Al Ghazal","year":"2013","unstructured":"Al Ghazal P, Herberger K, Schaller J et al (2013) Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients. Orphanet J Rare Dis 8:136\u2013136","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2098_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B (Methodological) 57(1):289\u2013300","journal-title":"J Roy Stat Soc B (Methodological)"},{"issue":"1","key":"2098_CR9","first-page":"10","volume":"24","author":"CE Fife","year":"2012","unstructured":"Fife CE, Carter MJ (2012) Wound Care outcomes and associated cost among patients treated in us outpatient wound centers: data from the US wound registry. Wounds 24(1):10\u201317","journal-title":"Wounds"},{"issue":"3","key":"2098_CR10","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7861\/clinmedicine.19-3-224","volume":"19","author":"C George","year":"2019","unstructured":"George C, Deroide F, Rustin M (2019) Pyoderma gangrenosum\u2014a guide to diagnosis and management. Clin Med 19(3):224\u2013228","journal-title":"Clin Med"},{"key":"2098_CR11","doi-asserted-by":"crossref","unstructured":"Xu A, Balgobind A, Strunk A, Garg A, Alloo A (2019) Prevalence estimates for pyoderma gangrenosum in the United States: an age- and sex-adjusted population analysis. J Am Acad Dermatol","DOI":"10.1016\/j.jaad.2019.08.001"},{"issue":"6","key":"2098_CR12","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/j.1365-2133.2011.10565.x","volume":"165","author":"AM Binus","year":"2011","unstructured":"Binus AM, Qureshi AA, Li VW, Winterfield LS (2011) Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol 165(6):1244\u20131250","journal-title":"Br J Dermatol"},{"issue":"9","key":"2098_CR13","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.1111\/ijd.12796","volume":"54","author":"V Shahi","year":"2015","unstructured":"Shahi V, Wetter DA (2015) Pyoderma gangrenosum associated with solid organ malignancies. Int J Dermatol 54(9):e351\u2013e357","journal-title":"Int J Dermatol"},{"issue":"6","key":"2098_CR14","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.abd.2019.06.001","volume":"94","author":"MJM Rodr\u00edguez-Z\u00fa\u00f1iga","year":"2019","unstructured":"Rodr\u00edguez-Z\u00fa\u00f1iga MJM, Heath MS, Gontijo JRV, Ortega-Loayza AG (2019) Pyoderma gangrenosum: a review with special emphasis on Latin America literature. An Bras Dermatol 94(6):729\u2013743","journal-title":"An Bras Dermatol"},{"issue":"4","key":"2098_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/jamadermatol.2017.5978","volume":"154","author":"HJ Ashchyan","year":"2018","unstructured":"Ashchyan HJ, Butler DC, Nelson CA et al (2018) The association of age with clinical presentation and comorbidities of pyoderma gangrenosum. JAMA Dermatol 154(4):409\u2013413","journal-title":"JAMA Dermatol"},{"issue":"10","key":"2098_CR16","first-page":"1023","volume":"14","author":"F Jockenh\u00f6fer","year":"2016","unstructured":"Jockenh\u00f6fer F, Herberger K, Schaller J et al (2016) Tricenter analysis of cofactors and comorbidity in patients with pyoderma gangrenosum. JDDG J Dtsch Dermatol Ges 14(10):1023\u20131030","journal-title":"JDDG J Dtsch Dermatol Ges"},{"issue":"1","key":"2098_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jdcr.2016.11.006","volume":"3","author":"D Niv","year":"2017","unstructured":"Niv D, Ramirez JA, Fivenson DP (2017) Pyoderma gangrenosum, acne, and hidradenitis suppurativa (PASH) syndrome with recurrent vasculitis. JAAD Case Rep 3(1):70\u201373","journal-title":"JAAD Case Rep"},{"issue":"1","key":"2098_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s41927-019-0098-z","volume":"3","author":"X Zhang","year":"2019","unstructured":"Zhang X, Jiao Y (2019) Takayasu arteritis with pyoderma gangrenosum: case reports and literature review. BMC Rheumatol 3(1):45","journal-title":"BMC Rheumatol"},{"issue":"9026","key":"2098_CR19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0140-6736(05)64704-6","volume":"348","author":"JC Phan","year":"1996","unstructured":"Phan JC, Hargadon AP, Salpeter SR (1996) Association between pyoderma gangrenosum and psoriasis. Lancet 348(9026):547","journal-title":"Lancet"},{"issue":"3","key":"2098_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2165\/11595240-000000000-00000","volume":"13","author":"I Ahronowitz","year":"2012","unstructured":"Ahronowitz I, Harp J, Shinkai K (2012) Etiology and management of pyoderma gangrenosum. Am J Clin Dermatol 13(3):191\u2013211","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"2098_CR21","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jaad.2015.06.021","volume":"73","author":"SF Braswell","year":"2015","unstructured":"Braswell SF, Kostopoulos TC, Ortega-Loayza AG (2015) Pathophysiology of pyoderma gangrenosum (PG): an updated review. J Am Acad Dermatol 73(4):691\u2013698","journal-title":"J Am Acad Dermatol"},{"key":"2098_CR22","doi-asserted-by":"crossref","unstructured":"Byrd AS, Carmona-Rivera C, O'Neil LJ, et al (2019) Neutrophil extracellular traps, B cells, and type I interferons contribute to immune dysregulation in hidradenitis suppurativa. Sci Transl Med 11(508)","DOI":"10.1126\/scitranslmed.aav5908"},{"issue":"6","key":"2098_CR23","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1053\/j.gastro.2007.10.031","volume":"133","author":"IR Williams","year":"2007","unstructured":"Williams IR, Parkos CA (2007) Colonic neutrophils in inflammatory bowel disease: double-edged swords of the innate immune system with protective and destructive capacity. Gastroenterology 133(6):2049\u20132052","journal-title":"Gastroenterology"},{"issue":"12","key":"2098_CR24","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1172\/JCI106754","volume":"50","author":"AG Mowat","year":"1971","unstructured":"Mowat AG, Baum J (1971) Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis. J Clin Investig 50(12):2541\u20132549","journal-title":"J Clin Investig"},{"key":"2098_CR25","unstructured":"Schadt C (2019) Pyoderma gangrenosum: pathogenesis, clinical features, and diagnosis. https:\/\/www-uptodate-com.sladenlibrary.hfhs.org\/contents\/pyoderma-gangrenosum-pathogenesis-clinical-features-and-diagnosis?search=pyoderma%2520gangrenosum&source=search_result&selectedTitle=1~93&usage_type=default&display_rank=1#H4373845. Accessed 18 Mar 2020 (Updated January 15, 2019)"},{"issue":"4","key":"2098_CR26","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1001\/jamadermatol.2017.5980","volume":"154","author":"E Maverakis","year":"2018","unstructured":"Maverakis E, Ma C, Shinkai K et al (2018) Diagnostic criteria of ulcerative pyoderma gangrenosum: a delphi consensus of international experts. JAMA Dermatol 154(4):461\u2013466","journal-title":"JAMA Dermatol"},{"issue":"5","key":"2098_CR27","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1001\/jamadermatol.2017.6197","volume":"154","author":"DG Li","year":"2018","unstructured":"Li DG, Xia FD, Khosravi H et al (2018) Outcomes of early dermatology consultation for inpatients diagnosed with cellulitis. JAMA Dermatol 154(5):537\u2013543","journal-title":"JAMA Dermatol"},{"issue":"1","key":"2098_CR28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/bjd.16446","volume":"179","author":"SJ Lockwood","year":"2018","unstructured":"Lockwood SJ, Li DG, Butler D, Tsiaras W, Joyce C, Mostaghimi A (2018) The validity of the diagnostic code for pyoderma gangrenosum in an electronic database. Br J Dermatol 179(1):216\u2013217","journal-title":"Br J Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02098-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-020-02098-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02098-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T23:51:04Z","timestamp":1625269864000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-020-02098-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,3]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["2098"],"URL":"https:\/\/doi.org\/10.1007\/s00403-020-02098-7","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,3]]},"assertion":[{"value":"24 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}